Article
Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline.
Nature communications - 4 Aug 2014
Da Cunha Violette, Davies Mark R, Douarre Pierre-Emmanuel, Rosinski-Chupin Isabelle, Margarit Immaculada, Spinali Sebastien, Perkins Tim, Lechat Pierre, Dmytruk Nicolas, Sauvage Elisabeth, Ma Laurence, Romi Benedetta, Tichit Magali, Lopez-Sanchez Maria-José, Descorps-Declere Stéphane, Souche Erika, Buchrieser Carmen, Trieu-Cuot Patrick, Moszer Ivan, Clermont Dominique, Maione Domenico, Bouchier Christiane, McMillan David J, Parkhill Julian, Telford John L, Dougan Gordan, Walker Mark J, Holden Matthew T G, Poyart Claire, Glaser Philippe
Abstract excerpt
Streptococcus agalactiae (Group B Streptococcus, GBS) is a commensal of the digestive and genitourinary tracts of humans that emerged as the leading cause of bacterial neonatal infections in Europe and North America during the 1960s. Due to the lack of epidemiological and genomic data, the reasons for this emergence are unknown. Here we show by comparative genome analysis and phylogenetic reconstruction of 229...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
